"The molecular maps or pathways that are activated in eczema had not been well defined," Guttman-Yassky said. "It was not clear whether it was a disease of immune activation or if the outer layer of the skin was deficient. We now understand that the disease is primarily immune driven ... which makes it much easier to cure."